{"DataElement":{"publicId":"5092497","version":"1","preferredName":"Knowledge Understanding and Judgement Scale Most Recent PSA Level 4 Point Scale","preferredDefinition":"Persons' stated knowledge of their most recent prostate specific antigen level, using a four-point Likert scale.","longName":"KUJ_PSA_LEVEL_SCL","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"5092406","version":"1","preferredName":"Knowledge, Understanding and Judgment Scale Most Recent PSA Level","preferredDefinition":"A questionnaire developed to assess a patient's knowledge of prostate cancer, understanding of treatment choices, and judgment of survival with and without treatment._A question about an individual's most recent self-reported PSA level.","longName":"5092397v1.0:5092404v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"5092397","version":"1","preferredName":"Knowledge, Understanding and Judgment Scale","preferredDefinition":"A questionnaire developed to assess a patient's knowledge of prostate cancer, understanding of treatment choices, and judgment of survival with and without treatment.","longName":"C124803","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Knowledge, Understanding and Judgment Scale","conceptCode":"C124803","definition":"A questionnaire developed to assess a patient's knowledge of prostate cancer, understanding of treatment choices, and judgment of survival with and without treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"276C284C-975C-F5EE-E050-BB89AD43463F","latestVersionIndicator":"Yes","beginDate":"2015-12-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-12-21","modifiedBy":"ONEDATA","dateModified":"2015-12-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"5092404","version":"1","preferredName":"Most Recent PSA Level","preferredDefinition":"A question about an individual's most recent self-reported PSA level.","longName":"C124806","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Most Recent PSA Level","conceptCode":"C124806","definition":"A question about an individual's most recent self-reported PSA level.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"276C284C-97C4-F5EE-E050-BB89AD43463F","latestVersionIndicator":"Yes","beginDate":"2015-12-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-12-21","modifiedBy":"ONEDATA","dateModified":"2015-12-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2524082","version":"1","preferredName":"Person Measure/Instrument Testing","preferredDefinition":"Process and results associated with self-reported measures and instruments, surveys, other tools","longName":"MEASURE/INSTRUMENT TESTING","context":"CCR","contextVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E838B40-6636-0A25-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-09-28","modifiedBy":"REEVESD","dateModified":"2008-11-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"KUJ:Knowledge, Understanding and Judgement Scale","workflowStatus":"RELEASED","registrationStatus":"Application","id":"276C284C-97D5-F5EE-E050-BB89AD43463F","latestVersionIndicator":"Yes","beginDate":"2015-12-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-12-21","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Created for Alliance A191402 study in Rave per request by K.Allen-Ziegler. mc 12/21/15","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5092371","version":"1","preferredName":"KUJ PSA Level 4 Point Scale","preferredDefinition":"A four point ordered reference standard related to the Knowledge, Understanding and Judgement (KUJ) scale for prostate specific antigen level.","longName":"KUJ_PSA_LVL_SCL","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"3","maxLength":"5","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"< 5","valueDescription":"PSA Level Less than Five","ValueMeaning":{"publicId":"5092375","version":"1","preferredName":"PSA Level Less than Five","longName":"5092375","preferredDefinition":"A blood concentration of prostate specific antigen below 5 ng/mL.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"PSA Level Less than Five","conceptCode":"C124828","definition":"A blood concentration of prostate specific antigen below 5 ng/mL.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"276B7749-4944-6628-E050-BB89AD432248","latestVersionIndicator":"Yes","beginDate":"2015-12-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-12-21","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2799FF88-AE41-15FE-E050-BB89AD433978","beginDate":"2015-12-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-12-23","modifiedBy":"ONEDATA","dateModified":"2015-12-23","deletedIndicator":"No"},{"value":"> 50","valueDescription":"PSA Level Greater than Fifty","ValueMeaning":{"publicId":"5092372","version":"1","preferredName":"PSA Level Greater than Fifty","longName":"5092372","preferredDefinition":"A blood concentration of prostate specific antigen above 50 ng/mL.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"PSA Level Greater than Fifty","conceptCode":"C124831","definition":"A blood concentration of prostate specific antigen above 50 ng/mL.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"276B7749-48D5-6628-E050-BB89AD432248","latestVersionIndicator":"Yes","beginDate":"2015-12-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-12-21","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2799FF88-AE55-15FE-E050-BB89AD433978","beginDate":"2015-12-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-12-23","modifiedBy":"ONEDATA","dateModified":"2015-12-23","deletedIndicator":"No"},{"value":"10-50","valueDescription":"PSA Level Ten to Fifty","ValueMeaning":{"publicId":"5092373","version":"1","preferredName":"PSA Level Ten to Fifty","longName":"5092373","preferredDefinition":"A blood concentration of prostate specific antigen between 10 and 50 ng/mL.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"PSA Level Ten to Fifty","conceptCode":"C124830","definition":"A blood concentration of prostate specific antigen between 10 and 50 ng/mL.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"276B7749-48FA-6628-E050-BB89AD432248","latestVersionIndicator":"Yes","beginDate":"2015-12-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-12-21","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"276B7749-4913-6628-E050-BB89AD432248","beginDate":"2015-12-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-12-21","modifiedBy":"ONEDATA","dateModified":"2015-12-21","deletedIndicator":"No"},{"value":"5-10","valueDescription":"PSA Level Five to Ten","ValueMeaning":{"publicId":"5092374","version":"1","preferredName":"PSA Level Five to Ten","longName":"5092374","preferredDefinition":"A blood concentration of prostate specific antigen between 5 and 10 ng/mL.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"PSA Level Five to Ten","conceptCode":"C124829","definition":"A blood concentration of prostate specific antigen between 5 and 10 ng/mL.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"276B7749-491F-6628-E050-BB89AD432248","latestVersionIndicator":"Yes","beginDate":"2015-12-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-12-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"276B7749-4938-6628-E050-BB89AD432248","beginDate":"2015-12-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-12-21","modifiedBy":"ONEDATA","dateModified":"2015-12-21","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2524082","version":"1","preferredName":"Person Measure/Instrument Testing","preferredDefinition":"Process and results associated with self-reported measures and instruments, surveys, other tools","longName":"MEASURE/INSTRUMENT TESTING","context":"CCR","contextVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E838B40-6636-0A25-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-09-28","modifiedBy":"REEVESD","dateModified":"2008-11-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2452834","version":"1","preferredName":"Scale","preferredDefinition":"an ordered reference standard.","longName":"C25664","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Scale","conceptCode":"C25664","definition":"An ordered reference standard used to measure incremental changes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"0D51E8D8-69DD-387C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-24","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-02-24","modifiedBy":"ONEDATA","dateModified":"2006-02-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"KUJ:Knowledge, Understanding and Judgement Scale","workflowStatus":"RELEASED","registrationStatus":"Application","id":"276B7749-48BD-6628-E050-BB89AD432248","latestVersionIndicator":"Yes","beginDate":"2015-12-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-12-21","modifiedBy":"COOPERM","dateModified":"2015-12-23","changeDescription":"Created for Alliance A191402 study in Rave per request by K.Allen-Ziegler. mc 12/21/15","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5090547","version":"1","longName":"KUJ (Knowledge, Understanding and Judgement Scale)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"5090548","version":"1","longName":"KUJ","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Your most recent PSA level is:","type":"Preferred Question Text","description":"Your most recent PSA level is:","url":null,"context":"NCIP"}],"origin":"KUJ:Knowledge, Understanding and Judgement Scale","workflowStatus":"RELEASED","registrationStatus":"Application","id":"276E21E2-5107-C12D-E050-BB89AD434B19","latestVersionIndicator":"Yes","beginDate":"2015-12-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-12-21","modifiedBy":"COOPERM","dateModified":"2015-12-23","changeDescription":"Created for Alliance A191402 study in Rave per request by K.Allen-Ziegler. mc 12/21/15","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}